334 related articles for article (PubMed ID: 17430164)
1. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?
Akdim F; van Leuven SI; Kastelein JJ; Stroes ES
Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of statins on endothelial dysfunction and vascular stiffness.
Dilaveris P; Giannopoulos G; Riga M; Synetos A; Stefanadis C
Curr Vasc Pharmacol; 2007 Jul; 5(3):227-37. PubMed ID: 17627566
[TBL] [Abstract][Full Text] [Related]
3. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
Chapman MJ
Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
[TBL] [Abstract][Full Text] [Related]
4. [Dyslipidemia, atherosclerosis, and vulnerable plaques: the effect of atorvastatin on atherosclerosis and plaque structure].
Tokgözoğlu L
Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():11-6. PubMed ID: 19404045
[TBL] [Abstract][Full Text] [Related]
5. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
Rosenson RS
Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
[TBL] [Abstract][Full Text] [Related]
6. Statins and cardioprotection--more than just lipid lowering?
Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.
Monroe VS; Kerensky RA; Rivera E; Smith KM; Pepine CJ
J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):23S-30S. PubMed ID: 12644337
[TBL] [Abstract][Full Text] [Related]
8. Statins and the endothelium.
Ii M; Losordo DW
Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
[TBL] [Abstract][Full Text] [Related]
9. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
Zhou Q; Liao JK
Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
[TBL] [Abstract][Full Text] [Related]
10. [Anti-inflammatory properties of statins in the study of atherosclerotic plaques in the endartectomized coronary arteries].
Chumachenko PV; Zhdanov VS; Belokon' EV; Shlychkova TP; Akchurin RS
Arkh Patol; 2009; 71(4):23-6. PubMed ID: 19824424
[TBL] [Abstract][Full Text] [Related]
11. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.
Ylä-Herttuala S; Bentzon JF; Daemen M; Falk E; Garcia-Garcia HM; Herrmann J; Hoefer I; Jukema JW; Krams R; Kwak BR; Marx N; Naruszewicz M; Newby A; Pasterkamp G; Serruys PW; Waltenberger J; Weber C; Tokgözoglu L
Thromb Haemost; 2011 Jul; 106(1):1-19. PubMed ID: 21670845
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
[TBL] [Abstract][Full Text] [Related]
13. Effects of statins beyond lipid lowering: potential for clinical benefits.
Almuti K; Rimawi R; Spevack D; Ostfeld RJ
Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
[TBL] [Abstract][Full Text] [Related]
14. The pleiotropic effects of statins.
Calabrò P; Yeh ET
Curr Opin Cardiol; 2005 Nov; 20(6):541-6. PubMed ID: 16234628
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
16. View of statins as antimicrobials in cardiovascular risk modification.
Kozarov E; Padro T; Badimon L
Cardiovasc Res; 2014 Jun; 102(3):362-74. PubMed ID: 24623278
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
[TBL] [Abstract][Full Text] [Related]
18. Effect of statins on atherosclerotic plaque.
Almeida SO; Budoff M
Trends Cardiovasc Med; 2019 Nov; 29(8):451-455. PubMed ID: 30642643
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
Shiomi M; Koike T; Ito T
Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
[TBL] [Abstract][Full Text] [Related]
20. [The non-lipid effects of statins].
Paragh G; Márk L; Katona E
Orv Hetil; 2004 Sep; 145(37):1903-10. PubMed ID: 15493621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
